Celltrion
068270.KS
#659
Rank
C$53.17 B
Marketcap
C$232.05
Share price
3.61%
Change (1 day)
31.96%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2026 (TTM): C$4.56

According to Celltrion 's latest financial reports the company's current EPS (TTM) is C$4.66. In 2025 the company made an earnings per share (EPS) of C$4.42 an increase over its 2024 EPS that were of C$1.68.

EPS history for Celltrion from 2007 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$4.563.01%
2025C$4.42163.66%
2024C$1.68-53.73%
2023C$3.63-2.08%
2022C$3.70-11.72%
2021C$4.192.03%
2020C$4.1182.8%
2019C$2.2518.31%
2018C$1.90-36.33%
2017C$2.98161.25%
2016C$1.142.86%
2015C$1.1117.84%
2014C$0.945.87%
2013C$0.89-70.85%
2012C$3.05134.09%
2011C$1.3043.59%
2010C$0.9174.49%
2009C$0.52317.8%
2008C$0.12-71.7%
2007C$0.44